부산대학교 도서관

T. Kimura; N. Tanaka; T. Maekawa; Y. Kiniwa; R. Okuyama; J. Asai; S. Matsushita; H. Uchi; H. Kato; K. Nagase; A. Kobayashi; A. Tanemura; T. Fujimura; Y. Fujisawa; K. Kunimoto; T. Ito; S. Mori; K. Yoshino; N. Yamazaki; H. Yano; Y. Komohara; T. Noda; K. Kiyotani; S. Fukushima

Communications Medicine, Vol 6, Iss 1, Pp 1-13 (2026)

Hayashi, N. ; Ono, M. ; Fukada, I. ; Yamazaki, M. ; Sato, N. ; Hosonaga, M. ; Wang, X. ; Kaneko, K. ; Arakawa, H. ; Habano, E. ; Kuga, A. ; Kataoka, A. ; Ueki, A. ; Kiyotani, K. ; Tonooka, A. ; Takeuchi, K. ; Kogawa, T. ; Kitano, S. ; Takano, T. ; Watanabe, M. ; Mori, S. ; Takahashi, S.

In ESMO Open August 2024 9(8)

Anastasopoulou V; Institute of Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schreiber H; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL, USA.; Department of Pathology, The University of Chicago, Chicago, IL, USA.; Committees on Cancer Biology and Immunology and the Cancer Center, The University of Chicago, Chicago, IL, USA.; Lee CE; Department of Pathology, The University of Chicago, Chicago, IL, USA.; Kiyotani K; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki-shi, Osaka, Japan.; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Hansmann L; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Nakamura Y; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki-shi, Osaka, Japan.; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Leisegang M; Institute of Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL, USA.; Wolf SP; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL, USA.; Department of Pathology, The University of Chicago, Chicago, IL, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Ito M; Institute of Clinical Medicine and Research, Research Center for Medical Sciences, The Jikei University School of Medicine, Chiba, Japan.; Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Koido S; The Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan.; Iwamoto T; Core Research Facilities, The Jikei University School of Medicine, Tokyo, Japan.; Morimoto S; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.; Fujiki F; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.; Sugiyama H; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.; Matsumoto S; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Effenberger C; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Kiyotani K; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Shiba K; Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Kouwenberg, Theodorus W., MD; van Dalen, Elvira C., MD, PhD; Mulder, Renée L., PhD; Armenian, Saro, DO, MPH; Feijen, Elizabeth A.M., PhD; Chow, Eric J., MD, MPH; Kosmidis, Helen, MD, PhD; Vormoor-Bürger, Britta J., MD, DrMed; Kiyotani, Chikako, MD, PhD; Nathan, Paul C., MD, MSc; Kapusta, Livia, MD, PhD; Grotenhuis, Heynric B., MD, PhD; Engels, Frederike K., PhD; Teske, Arco J., MD, PhD; Tragiannidis, Athanasios, MD, PhD; Slieker, Martijn G., MD, PhD; Ozono, Shuichi, MD, PhD; Nohria, Anju, MD, MSc; Sláma, Tomáš, MD, PhD; Skinner, Roderick, MB, ChB; Hudson, Melissa M., MD; Kremer, Leontien C.M., MD, PhD; Ehrhardt, Matthew J., MD, MS; Mavinkurve-Groothuis, Annelies M.C., MD, PhD

JACC: CardioOncology. 7(6):683-690

Kazumi Okamura; Lifang Wang; Satoshi Nagayama; Makiko Yamashita; Tomohiro Tate; Saki Matsumoto; Manabu Takamatsu; Shigehisa Kitano; Kazuma Kiyotani; Yusuke Nakamura

OncoImmunology, Vol 13, Iss 1 (2024)

Province, M. A.; Goetz, M. P.; Brauch, H.; Flockhare, D. A.; Hebert, J. M.; Whaley, R.; Suman, V. J.; Schroth, W.; Winter, S.; Zembutsu, H.; Mushiroda, T.; Newman, W. G.; Lee, M-TM.; Ambrosone, C. B.; Beckmann, M. W.; Choi, J-Y; Dieudonne, A-S; Fasching, P. A.; Ferraldeschi, R.; Gong, L.; Haschke-Becher, E.; Howel, A.; Jordan, L. B.; Hamann, U.; Kiyotani, K.; Krippl, P.; Lambrechts, D.; Latif, A.; Langsenlehner, U.; Lorizio, W.; Neven, P.; Nguyen, A. T.; Park, B-W.; Purdie, C. A.; Quinlan, P.; Renner, W.; Schmidt, M.; Schwab, M.; Shin, J-G; Stingl, J. C.; Wegman, Pia, 1964; Wingren, Sten, 1950; Wu, A. H. B.; Ziv, E.; Zirpoli, G.; Thompson, A. M.; Jordan, V. C.; Nakamura, Y.; Altman, R. B.; Ames, M. M.; Klein, T. E.

Clinical Pharmacology and Therapeutics. 95(2):216-227

Morisaki S; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Onishi H; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Morisaki T; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Kubo M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Umebayashi M; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Tanaka H; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Koya N; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Nakagawa S; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Tsujimura K; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Yoshimura S; Cancer Precision Medicine Inc., Kanagawa, Japan.; Yew PY; Cancer Precision Medicine Inc., Kanagawa, Japan.; Kiyotani K; National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.; Nakamura Y; National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.; Nakamura M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Torisu T; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Kitazono T; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Morisaki T; Fukuoka General Cancer Clinic, Fukuoka, Japan.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Oyama K; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Nakata K; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Abe T; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Hirotaka K; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Fujimori N; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Kiyotani K; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan.; Iwamoto C; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Ikenaga N; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Morisaki S; Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, Japan.; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Umebayashi M; Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, Japan.; Tanaka H; Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, Japan.; Koya N; Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, Japan.; Nakagawa S; Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, Japan.; Tsujimura K; Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, Japan.; Yoshimura S; Corporate Headquarters, Cancer Precision Medicine Inc., Kawasaki, Japan.; Onishi H; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Nakamura Y; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan.; Nakamura M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Morisaki T; Department of Cancer Immunotherapy, Fukuoka General Cancer Clinic, Fukuoka, Japan.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Zhao P; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka, Japan.; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.; Effenberger C; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Matsumoto S; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Tanaka T; Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.; Bioresource Research Support Center, Institute of Science Tokyo, Tokyo, Japan.; Nakamura Y; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka, Japan.; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Kiyotani K; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka, Japan.; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Effenberger C; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Wu X; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka, Japan.; Zhao P; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka, Japan.; Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.; Matsumoto S; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Nakamura Y; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka, Japan.; Kiyotani K; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka, Japan.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Takami H; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Yoshida K; Next-generation Precision Medicine Research Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Matsuoka Y; Next-generation Precision Medicine Research Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Sasagawa S; Molecular Biology Laboratory, Research Institute, Nozaki Tokushukai Hospital, Tanigawa 2-10-50, Daito, Osaka, 574-0074, Japan.; Nagamine N; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Kukita Y; Laboratory of Genomic Pathology, Osaka International Cancer Institute, 3- 1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Kiyotani K; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), Health and Nutrition (NIBIOHN), National Institute of Biomedical Innovation, Ibaraki-shi, Osaka, Japan.; Yoshimura Y; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Suzuki R; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Tamiya H; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Kakunaga S; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Yagi T; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Nakai S; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Imura Y; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Okada S; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Yoshida KI; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Takenaka S; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Wakamatsu T; Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan. evolutionhhh49@yahoo.co.jp.; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. evolutionhhh49@yahoo.co.jp.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Wu AC; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka 567-0085, Japan.; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Nakamura Y; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka 567-0085, Japan.; Kiyotani K; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka 567-0085, Japan.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Wolf SP; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA.; Department of Pathology, University of Chicago, Chicago, IL, USA.; Leisegang M; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA.; Institute of Immunology, Charité-Universitätsmedizin Berlin, Campus Berlin Buch, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Steiner M; Department of Pathology, University of Chicago, Chicago, IL, USA.; Wallace V; Department of Pathology, University of Chicago, Chicago, IL, USA.; Kiyotani K; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki-shi, Osaka, Japan.; Hu Y; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL, USA.; Pritzker School of Medicine, University of Chicago, Chicago, IL, USA.; Rosenberger L; Institute of Immunology, Charité-Universitätsmedizin Berlin, Campus Berlin Buch, Berlin, Germany.; Huang J; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL, USA.; Committees on Cancer Biology and Immunology and Cancer Center, University of Chicago, Chicago, IL, USA.; Schreiber K; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA.; Department of Pathology, University of Chicago, Chicago, IL, USA.; Nakamura Y; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki-shi, Osaka, Japan.; Schietinger A; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Schreiber H; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA.; Department of Pathology, University of Chicago, Chicago, IL, USA.; Committees on Cancer Biology and Immunology and Cancer Center, University of Chicago, Chicago, IL, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

Hayashi N; Department of Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan. naomi.hayashi@jfcr.or.jp.; Department of Clinical Genetic Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan. naomi.hayashi@jfcr.or.jp.; Mori S; Project for Development of Innovative Research On Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Ohmoto A; Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, 1275 York Avenue, New York, NY, 10065, USA.; Fukada I; Department of Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Department of Breast Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Yamazaki M; Department of Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Center for Advanced Medical Development, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Hosonaga M; Department of Breast Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Wang X; Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Ueki A; Department of Clinical Genetic Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Kiyotani K; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), Health and Nutrition (NIBIOHN), National Institutes of Biomedical Innovation, 7-6-8, Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan.; Tonooka A; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Takeuchi K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Takahashi S; Department of Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.; Center for Advanced Medical Development, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.

Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Aguilar, H; Urruticoechea, A; Halonen, P; Kiyotani, K; Mushiroda, T; Barril, X; Serra-Musach, J; Islam, A; Caizzi, L; Di, Croce L

BREAST CANCER RESEARCH. 16(3)

Leisegang, M.; Engels, B.; Schreiber, K.; Yew, P.Y.; Kiyotani, K.; Idel, C.; Arina, A.; Duraiswamy, J.; Weichselbaum, R.R.; Uckert, W.; Nakamura, Y.; Schreiber, H.

Clinical Cancer Research. 22:2734-2743

Fukada I; Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Breast Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Mori S; Division of Cancer Genomics, Japanese Foundation for Cancer Research, Cancer Institute, Tokyo, Japan.; Hayashi N; Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Hosonaga M; Breast Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Xiaofei W; Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Yamazaki M; Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; The Advanced Medical Development, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Ueki A; Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Kiyotani K; Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Tonooka A; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Takeuchi K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Ueno T; The Advanced Medical Development, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Breast Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Takahashi S; Genomic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

Morisaki S; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Onishi H; Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Morisaki T; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Kubo M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Umebayashi M; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Tanaka H; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Koya N; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Nakagawa S; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Tsujimura K; Fukuoka General Cancer Clinic, Fukuoka, Japan.; Yoshimura S; Corporate Headquarters, Cancer Precision Medicine Inc., Kawasaki, Japan.; Yew PY; Corporate Headquarters, Cancer Precision Medicine Inc., Kawasaki, Japan.; Kiyotani K; National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan.; Nakamura Y; National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan.; Nakamura M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Kitazono T; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Morisaki T; Fukuoka General Cancer Clinic, Fukuoka, Japan.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Haraguchi M; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-Ku, Tokyo, 135-8550, Japan.; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.; Kiyotani K; Immunopharmacogenomics Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Tate T; Immunopharmacogenomics Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Sakata S; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Sagawa R; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-Ku, Tokyo, 135-8550, Japan.; Takagi S; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-Ku, Tokyo, 135-8550, Japan.; Nagayama S; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Surgery, Uji-Tokushukai Medical Center, Kyoto, Japan.; Takeuchi K; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Takahashi K; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.; Katayama R; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-Ku, Tokyo, 135-8550, Japan. ryohei.katayama@jfcr.or.jp.; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan. ryohei.katayama@jfcr.or.jp.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE